Cullinan Therapeutics Stock (NASDAQ: CGEM) stock price, news, charts, stock research, profile.
Open | $18.53 |
Close | - |
Volume / Avg. | 76.73K / 1.00M |
Day Range | 18.39 - 19.38 |
52 Wk Range | 7.64 - 30.19 |
Market Cap | $1.09B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 15.79% |
Days to Cover | 5.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.
Other companies in Cullinan Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
There is no analysis for Cullinan Therapeutics.
Cullinan Therapeutics has a consensus price target of $29.14.
The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $18.85 last updated Today at July 18, 2024 at 11:12 AM EDT.
There are no upcoming dividends for Cullinan Therapeutics.
Cullinan Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Cullinan Therapeutics.
Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.